If you are wondering, can weight loss injections cause infertility, current evidence does not show that medicines such as Wegovy, Mounjaro or Saxenda cause permanent infertility. However, these treatments are generally not recommended during pregnancy, and people planning to conceive may need to stop treatment beforehand according to medicine-specific prescribing guidance.

The relationship between weight loss injections and fertility is complex. Body weight, PCOS, insulin resistance and metabolic health can affect reproductive function, while weight loss may influence ovulation and conception. Evidence varies between medicines, so fertility changes during treatment do not prove infertility and should be considered alongside UK pre-conception guidance.

GLP-1 / GIP

Mounjaro

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
  • ✔ ~22.5% average body weight loss
  • ✔ Significant weight reduction
  • ✔ Improves blood sugar levels
  • ✔ Clinically proven weight loss
GLP-1

Wegovy

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
  • ✔ ~16.9% average body weight loss
  • ✔ Boosts metabolic & cardiovascular health
  • ✔ Proven, long-established safety profile
  • ✔ Weekly injection, easy to use

Key Facts About Mounjaro and Fertility

  • Current evidence does not establish Wegovy, Mounjaro or Saxenda as causes of permanent infertility.
  • Weight loss and improved metabolic health may support ovulation and reproductive function in some people.
  • Mounjaro can reduce the reliability of oral hormonal contraception when starting treatment or increasing the dose.
  • Weight loss injections are not recommended during pregnancy due to limited human safety data and potential fetal risks.
  • Wegovy should be stopped at least two months and Mounjaro at least one month before a planned pregnancy.
  • Pregnancy or fertility treatment should be planned with appropriate guidance from your prescriber or fertility specialist.

How Weight Loss Injections May Relate to Reproductive Health

Weight loss injections do not primarily target the reproductive system. Wegovy and Saxenda act on GLP-1 receptors, while Mounjaro targets GIP and GLP-1 pathways. By regulating appetite, food intake and blood glucose, these medicines support weight management, which may indirectly influence reproductive health through metabolic and hormonal changes.

Excess weight can disrupt hormones, menstrual regularity and ovulation in women and may affect reproductive hormones and semen parameters in men. Weight loss and improved metabolic health may therefore support factors involved in conception. However, research on direct fertility effects remains limited, making it important to distinguish these indirect changes.

Do Weight Loss Injections Cause Infertility?

Current evidence does not show that Wegovy, Mounjaro or Saxenda cause permanent infertility. Infertility is not listed as a recognised adverse effect in UK product information, although clinical trials have not primarily assessed long-term fertility. Animal studies have reported reproductive effects, but these findings do not establish infertility in humans.

Substantial weight loss and metabolic changes may affect menstrual cycles or ovulation without indicating permanent infertility. Conversely, losing excess weight may improve hormonal balance and ovulation in some people. Weight loss injections are avoided during pregnancy for safety reasons, and anyone planning to conceive should follow medicine-specific guidance from their prescriber.

Achieve Sustainable Weight Loss

  • check Clinically Proven Treatments
  • check Balanced Nutrition Plan
  • check Expert Professional Guidance
Start Your Free Consultation Now
CTA Image

How Can Weight Loss Injections Influence Fertility and Conception?

Weight loss injections can influence fertility through several indirect pathways. Changes in body weight, insulin sensitivity and hormonal health may affect ovulation and reproductive function, while certain treatments can also have implications for contraception. Understanding these different pathways helps distinguish medication effects from changes associated with weight loss itself.

Weight Loss and Fertility

For people with obesity or PCOS, excess weight and insulin resistance can contribute to irregular ovulation and hormonal disruption. Weight loss achieved while using treatments such as Wegovy or Mounjaro may improve metabolic health and support more regular ovulation in some women. However, these medicines are not fertility treatments, and individual responses can vary.

Mounjaro and Contraception

Mounjaro (tirzepatide) delays gastric emptying, which can reduce the reliability of oral hormonal contraceptives, particularly when treatment begins or the dose increases. Women using the contraceptive pill may therefore need additional or non-oral contraception for a specified period. This potential interaction is separate from the medicine’s effects on fertility itself.

Male Fertility and Weight Loss

Obesity can be associated with hormonal changes and poorer semen parameters, including sperm concentration and motility. Losing excess weight and improving metabolic health may support reproductive health in some men. Evidence on the direct effects of weight loss injections on male fertility remains limited, so these potential benefits should not be attributed to the medicines themselves.

What Are the Risks of Weight Loss Injections When Trying to Conceive?

Weight loss injections such as Wegovy and Mounjaro are not recommended during pregnancy and should be stopped before trying to conceive. The main considerations involve fetal exposure, nutrition, dehydration and the time needed for each medicine to leave the body.

Potential Risk to the Baby

Human pregnancy data for weight loss injections remain limited, while animal studies have raised concerns about fetal development and pregnancy outcomes. This does not prove the same effects occur in humans, but avoiding exposure during pregnancy is recommended as a precaution.

Nutrition and Dehydration

Weight loss injections can reduce appetite and cause nausea, vomiting or diarrhoea. Around conception and during pregnancy, these effects may increase the risk of inadequate nutrition or dehydration. Rapid weight loss may also make it harder to meet the body’s increased nutritional requirements.

When to Stop Treatment

Stopping times differ between medicines because each treatment remains in the body for a different period. Weight loss injections should therefore be discontinued far enough in advance of a planned pregnancy to limit fetal exposure. The exact timeframe depends on the medicine, so follow product-specific guidance and your prescriber’s advice.

If You Become Pregnant

If you discover you are pregnant while taking a weight loss injection, stop the treatment and contact your healthcare professional promptly. Exposure does not necessarily mean the pregnancy has been harmed, but your treatment and individual circumstances should be medically reviewed to determine the appropriate next steps.

If you are planning a pregnancy while using weight loss injections, an online consultation can help you understand when to stop treatment and discuss the appropriate next steps.

How Long Before Pregnancy Should You Stop Weight Loss Injections?

The recommended stopping time depends on the medicine because weight loss injections remain in the body for different periods. Wegovy (semaglutide) should be stopped at least two months before a planned pregnancy, allowing sufficient time for semaglutide to clear from the body. Mounjaro (tirzepatide) should be stopped at least one month before conception, while Saxenda (liraglutide) should be discontinued when pregnancy is planned.

Semaglutide requires particular consideration because of its longer elimination time. Discuss pregnancy plans with your prescriber before making any treatment changes. This allows treatment to be stopped at the appropriate time while your weight, nutritional needs and metabolic health are managed as you prepare for conception.

Can You Use Weight Loss Injections Before IVF or Fertility Treatment?

Weight loss injections may be used before fertility treatment when clinically appropriate, particularly to reduce BMI or improve metabolic health. Achieving a healthier weight may support ovulation, treatment eligibility and pregnancy health in some people. However, these medicines do not directly improve IVF outcomes and are not considered fertility treatments themselves.

Treatment may need to stop before ovarian stimulation, procedures involving anaesthesia or sedation, and embryo transfer. Timing varies by medicine, with semaglutide requiring a longer washout before pregnancy. Your weight-management prescriber and fertility specialist should coordinate treatment to ensure appropriate discontinuation without unnecessarily disrupting your fertility care or weight-management plan.

Conclusion: Weight Loss Injections and Fertility

Overall, current evidence provides no established link between weight loss injections and permanent infertility. Their relationship with reproductive health is more nuanced, as weight loss and metabolic improvements may alter fertility in some people. Importantly, restrictions around their use during pregnancy reflect safety precautions and should not be interpreted as evidence of infertility.

Planning ahead is important when trying to conceive or preparing for fertility treatment. Wegovy, Mounjaro and Saxenda have specific pregnancy guidance, making clinical advice essential. Mayfair Weight Loss Clinic offers an online consultation where a qualified prescriber can review your treatment and provide personalised guidance for pregnancy and weight-management plans.

FAQs About Weight Loss Injections and Fertility

Can weight loss injections affect your periods?

Changes in body weight, calorie intake and metabolic health can influence menstrual cycles. Some people may notice periods becoming irregular during significant weight loss, although this does not necessarily indicate a fertility problem.

Can weight loss injections affect egg quality?

There is currently insufficient human evidence to show that weight loss injections directly improve or damage egg quality. Age, ovarian reserve, health conditions and lifestyle factors are among the established influences on reproductive health.

Can weight loss injections affect ovarian reserve?

There is no established evidence that Wegovy, Mounjaro or Saxenda reduce ovarian reserve. Research specifically examining markers such as anti-Müllerian hormone (AMH) during treatment remains limited.

Do weight loss injections affect reproductive hormones?

Weight loss and improved insulin sensitivity can lead to changes in hormones involved in reproductive function. However, this does not mean weight loss injections directly regulate reproductive hormones, and individual responses may differ.

Can weight loss injections affect sperm quality?

Evidence on the direct effects of weight loss injections on sperm remains limited. Improvements in weight and metabolic health may support reproductive health in men with obesity, but the medicines themselves are not treatments for male infertility.

Can weight loss injections cause miscarriage?

Human evidence is currently insufficient to determine whether weight loss injections directly increase miscarriage risk. These medicines are not recommended during pregnancy, and anyone exposed during pregnancy should contact a healthcare professional for individual advice.

Can I have fertility tests while taking weight loss injections?

Fertility investigations may still be possible while using weight loss injections. However, tell your fertility specialist about all medicines you take, as weight changes and underlying metabolic conditions may be relevant when interpreting certain results and planning further care.

Will fertility decrease after stopping weight loss injections?

There is no established evidence that stopping weight loss injections causes a lasting reduction in fertility. Fertility may instead change alongside subsequent changes in weight, menstrual regularity, metabolic health or underlying reproductive conditions.

GLP-1 / GIP

Mounjaro

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
  • ✔ ~22.5% average body weight loss
  • ✔ Significant weight reduction
  • ✔ Improves blood sugar levels
  • ✔ Clinically proven weight loss
GLP-1

Wegovy

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
  • ✔ ~16.9% average body weight loss
  • ✔ Boosts metabolic & cardiovascular health
  • ✔ Proven, long-established safety profile
  • ✔ Weekly injection, easy to use